Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Humanigen Inc.

www.kalobios.com

Latest From Humanigen Inc.

Proceeds From Chagas Treatment Priority Review Voucher Will Help Ensure Access

US FDA approved its first treatment for the tropical disease and awarded a priority review voucher that will be sold as per agreement between development partners.

Infectious Diseases Rare Diseases

Pulmotect Seeks Quick-To-Market Path For Rapid-Acting Respiratory Drug

Selected by NIH and NSF for the Innovation Zone at BIO 2017, the Houston biotech's synthetic broad-spectrum drug has shown activity in animal models against every pathogen tested. Pulmotect hopes PUL-042 can prevent exacerbations in COPD patients who develop upper respiratory infections.

Respiratory Infectious Diseases

Keeping Track: Oncology Announcements, Priority Review Vouchers Continue To Pile Up

The latest drug development news and US FDA highlights from our Performance Tracker.

Complete Response Letters Drug Review

Shaping A Shkreli Bill: Voucher Abuse Solution May Stumble On FDA Effects

House bill that would require new clinical studies from sponsor for tropical disease priority review vouchers met with industry concerns about limiting the US agency's flexibility.

Pricing Debate Rare Diseases
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • KaloBios Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Humanigen Inc.
  • Senior Management
  • Cameron Durrant, MD, CEO
    Greg Jester, CFO
    Niv Caviar, Head, Corp. & Bus. Dev.
    Morgan Lam, CSO
  • Contact Info
  • Humanigen Inc.
    1000 Marina Blvd.
    Ste. 250
    Brisbane, CA 94005
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register